newsfilter
← Latest News
ACCESS Newswire·

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

PHOENIX, AZ / ACCESSWIRE / December 20, 2023 / Creative Medical Technology Holdings, Inc. , a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their